Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trials

"Of course we need to see and wait to see how the vaccine's efficacy
and safety is demonstrated, hopefully in the coming months," Nanette
Cocero, the global head of Pfizer Vaccines, said on a conference call.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-depending-on-trials/articleshow/75475414.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply